These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
154 related items for PubMed ID: 5720791
1. Tissue and medium antigens in vaccines--discussion. Feldman HA. Natl Cancer Inst Monogr; 1968 Dec; 29():193-4. PubMed ID: 5720791 [No Abstract] [Full Text] [Related]
2. Tissue and medium antigens in vaccines. Coriell LL. Natl Cancer Inst Monogr; 1968 Dec; 29():179-91. PubMed ID: 4976862 [No Abstract] [Full Text] [Related]
3. Clinical experience with vaccines produced in the human diploid cell line WI-38. Andzaparidze OG. Natl Cancer Inst Monogr; 1968 Dec; 29():477-84. PubMed ID: 4976367 [No Abstract] [Full Text] [Related]
4. Characteristics of cell culture systems: viral flora of tissue sources and tissue and medium antigens in vaccines--summary. Sigel MM, von Magnus H. Natl Cancer Inst Monogr; 1968 Dec; 29():551-4. PubMed ID: 4976867 [No Abstract] [Full Text] [Related]
5. Viral flora of tissue sources and tissue and medium antigens in vaccines--general comments. Vasington PJ. Natl Cancer Inst Monogr; 1968 Dec; 29():205-6. PubMed ID: 4976358 [No Abstract] [Full Text] [Related]
6. Viral flora of tissue sources and tissue and medium antigens in vaccines--general comments. Fellowes ON. Natl Cancer Inst Monogr; 1968 Dec; 29():209-14. PubMed ID: 5720794 [No Abstract] [Full Text] [Related]
7. Viral flora of tissue sources and tissue and medium antigens in vaccines--general comments. Jensen KE. Natl Cancer Inst Monogr; 1968 Dec; 29():207-8. PubMed ID: 5720793 [No Abstract] [Full Text] [Related]
8. Cell cultures for virus vaccine production. General conclusions from the conference. Merchant DJ. Natl Cancer Inst Monogr; 1968 Dec; 29():583-4. PubMed ID: 5720811 [No Abstract] [Full Text] [Related]
9. Experience with an established cell line for veterinary vaccine production. Brown AL. Natl Cancer Inst Monogr; 1968 Dec; 29():523-6. PubMed ID: 4305440 [No Abstract] [Full Text] [Related]
10. Viral flora of primate tissues--discussion. Malherbe H. Natl Cancer Inst Monogr; 1968 Dec; 29():177-8. PubMed ID: 5720790 [No Abstract] [Full Text] [Related]
11. Industrial production of primary tissue culture. Warren J. Natl Cancer Inst Monogr; 1968 Dec; 29():35-43. PubMed ID: 4976363 [No Abstract] [Full Text] [Related]
12. Vaccines produced in diploid cell lines--discussion. Perkins FT. Natl Cancer Inst Monogr; 1968 Dec; 29():495-7. PubMed ID: 5720803 [No Abstract] [Full Text] [Related]
13. Monitoring vaccines for human oncogenicity. Miller RW. Natl Cancer Inst Monogr; 1968 Dec; 29():453-5. PubMed ID: 4305436 [No Abstract] [Full Text] [Related]
14. Viral oncogenesis and results of inoculation of normal and transformed cells into nonhuman primates--discussion. Stevenson RE. Natl Cancer Inst Monogr; 1968 Dec; 29():333-4. PubMed ID: 4976361 [No Abstract] [Full Text] [Related]
15. Vaccines produced in heteroploid cell lines--discussion. Hull RN. Natl Cancer Inst Monogr; 1968 Dec; 29():471-2. PubMed ID: 4976366 [No Abstract] [Full Text] [Related]
16. Latent viral infections in donor tissues and in recipients of vaccines. Melnick JL. Natl Cancer Inst Monogr; 1968 Dec; 29():337-49. PubMed ID: 4305432 [No Abstract] [Full Text] [Related]
17. Cell substrates for human virus vaccine preparation--general comments. Hayflick L. Natl Cancer Inst Monogr; 1968 Dec; 29():83-91. PubMed ID: 5720814 [No Abstract] [Full Text] [Related]